1 Min Read
Oct 10 (Reuters) - Recro Pharma Inc:
* Recro Pharma Inc - IV meloxicam 30mg demonstrates statistically significant reductions in pain, along with reductions in opioid rescue use Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.